CGON
Price
$42.61
Change
+$1.24 (+3.00%)
Updated
Dec 3 closing price
Capitalization
3.44B
Intraday BUY SELL Signals
KRYS
Price
$217.73
Change
+$2.67 (+1.24%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
6.24B
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs KRYS

Header iconCGON vs KRYS Comparison
Open Charts CGON vs KRYSBanner chart's image
CG Oncology
Price$42.61
Change+$1.24 (+3.00%)
Volume$1.05M
Capitalization3.44B
Krystal Biotech
Price$217.73
Change+$2.67 (+1.24%)
Volume$2.97K
Capitalization6.24B
CGON vs KRYS Comparison Chart in %
View a ticker or compare two or three
VS
CGON vs. KRYS commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and KRYS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CGON: $41.37 vs. KRYS: $215.06)
Brand notoriety: CGON and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 41% vs. KRYS: 28%
Market capitalization -- CGON: $3.49B vs. KRYS: $6.24B
CGON [@Biotechnology] is valued at $3.49B. KRYS’s [@Biotechnology] market capitalization is $6.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while KRYS’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 4 bearish.
  • KRYS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CGON is a better buy in the short-term than KRYS.

Price Growth

CGON (@Biotechnology) experienced а -9.10% price change this week, while KRYS (@Biotechnology) price change was -0.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

KRYS is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($6.24B) has a higher market cap than CGON($3.44B). CGON YTD gains are higher at: 44.247 vs. KRYS (37.278). KRYS has higher annual earnings (EBITDA): 158M vs. CGON (-157.09M). KRYS (682M) and CGON (661M) have equal amount of cash in the bank . CGON has less debt than KRYS: CGON (994K) vs KRYS (9.68M). KRYS has higher revenues than CGON: KRYS (359M) vs CGON (551K).
CGONKRYSCGON / KRYS
Capitalization3.44B6.24B55%
EBITDA-157.09M158M-99%
Gain YTD44.24737.278119%
P/E RatioN/A32.25-
Revenue551K359M0%
Total Cash661M682M97%
Total Debt994K9.68M10%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
23
SMR RATING
1..100
53
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONKRYS
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
77%
Momentum
ODDS (%)
Bullish Trend 6 days ago
69%
Bullish Trend 6 days ago
85%
MACD
ODDS (%)
Bullish Trend 6 days ago
62%
Bullish Trend 6 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 29 days ago
80%
Bearish Trend 15 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
75%
Aroon
ODDS (%)
Bearish Trend 6 days ago
85%
Bullish Trend 6 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
KRYS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACGIX23.81N/A
N/A
Invesco Growth and Income A
GABEX5.31N/A
N/A
Gabelli Equity Income AAA
MGBRX17.95N/A
N/A
MFS Global Total Return R2
FFIFX27.82N/A
N/A
American Funds Income Fund of Amer 529F3
ARVIX13.69N/A
N/A
ARGA International Value Institutional

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-4.35%
SYRE - CGON
58%
Loosely correlated
-0.91%
ACLX - CGON
57%
Loosely correlated
-2.03%
IDYA - CGON
56%
Loosely correlated
-1.75%
NUVL - CGON
55%
Loosely correlated
-1.37%
XNCR - CGON
54%
Loosely correlated
-3.15%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with VRDN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-0.02%
VRDN - KRYS
48%
Loosely correlated
-3.26%
IDYA - KRYS
48%
Loosely correlated
-1.75%
CGON - KRYS
48%
Loosely correlated
-4.35%
XNCR - KRYS
48%
Loosely correlated
-3.15%
CLDX - KRYS
47%
Loosely correlated
+2.85%
More